Here's the live share price of Zydus Lifesciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | -1.24 | 4.33 | 21.24 | 30.77 | 17.33 | 24.07 | 12.01 |
| Sun Pharmaceutical Industries | 2.76 | 7.40 | 14.35 | 16.23 | 12.30 | 21.85 | 23.12 |
| Divi's Laboratories | 6.35 | 8.73 | 16.33 | 15.26 | 5.84 | 25.02 | 9.22 |
| Torrent Pharmaceuticals | 2.10 | 10.21 | 19.57 | 23.66 | 44.48 | 36.71 | 26.98 |
| Cipla | 0.48 | 4.13 | 17.27 | 2.90 | -3.51 | 11.71 | 8.05 |
| Lupin | 0.49 | 8.62 | 5.57 | 13.47 | 26.55 | 38.44 | 16.07 |
| Mankind Pharma | 1.67 | 6.30 | 19.22 | 16.28 | -4.59 | 11.65 | 12.19 |
| Dr. Reddy's Laboratories | -7.63 | -2.62 | 2.25 | 5.97 | -1.22 | 6.96 | 2.93 |
| Aurobindo Pharma | -0.45 | 10.16 | 12.68 | 32.21 | 34.53 | 28.01 | 9.98 |
| Laurus Labs | 6.13 | 12.28 | 39.65 | 44.92 | 88.59 | 64.39 | 18.84 |
| Biocon | 10.18 | 5.06 | 24.78 | 15.83 | 12.07 | 18.60 | 1.83 |
| Alkem Laboratories | -0.03 | 5.04 | 0.53 | -3.93 | 13.63 | 16.79 | 11.08 |
| Glenmark Pharmaceuticals | 3.65 | 6.93 | 1.98 | 15.22 | 3.50 | 48.65 | 28.26 |
| Abbott India | 4.83 | 4.69 | 5.89 | -1.00 | -19.88 | 5.69 | 9.63 |
| Ipca Laboratories | 4.49 | 16.76 | 25.04 | 21.94 | 25.15 | 33.43 | 11.60 |
| Ajanta Pharma | 4.13 | 11.65 | 18.24 | 27.41 | 26.46 | 33.21 | 19.06 |
| Anthem Biosciences | 0.22 | -2.94 | 2.90 | 21.90 | 2.74 | 0.90 | 0.54 |
| GlaxoSmithKline Pharmaceuticals | 2.29 | 16.03 | 2.45 | 4.96 | -22.96 | 21.11 | 9.80 |
| Gland Pharma | -0.71 | 11.94 | 40.95 | 45.23 | 30.53 | 29.59 | -8.40 |
| J B Chemicals & Pharmaceuticals | 2.41 | 12.53 | 26.03 | 31.09 | 50.95 | 24.75 | 22.45 |
Source: Dion Global
Over the last one year, Zydus Lifesciences has gained 17.33% compared to peers like Sun Pharmaceutical Industries (12.30%), Divi's Laboratories (5.84%), Torrent Pharmaceuticals (44.48%). From a 5 year perspective, Zydus Lifesciences has underperformed peers relative to Sun Pharmaceutical Industries (23.12%) and Divi's Laboratories (9.22%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,148.66 | 1,139.52 |
| 10 | 1,135.31 | 1,135 |
| 20 | 1,112.23 | 1,119.49 |
| 50 | 1,059.17 | 1,069.99 |
| 100 | 983.14 | 1,019.86 |
| 200 | 962.44 | 985.09 |
Source: Dion Global
In the latest quarter, Zydus Lifesciences remained same as its previous close in promoter holding, while DII stake increased to 11.27%, FII holding unchanged at 6.89%, and public shareholding moved down to 6.83% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 1,05,00,000 | 2.06 | 1,131.59 | |
| 28,24,440 | 0.4 | 304.39 | |
| 6,07,938 | 0.38 | 65.52 | |
| 3,51,000 | 0.34 | 37.83 | |
| 3,00,000 | 1.08 | 32.33 | |
| 1,82,878 | 2.52 | 19.71 | |
| 92,700 | 0.18 | 9.99 | |
| 78,254 | 0.59 | 8.43 | |
| 41,400 | 0.12 | 4.46 | |
| 34,200 | 0.19 | 3.69 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Jul 14, 2026, 11:28 PM IST IST | Zydus Lifesciences - Clarification sought from Zydus Lifesciences Ltd |
| Jul 10, 2026, 10:45 PM IST IST | Zydus Lifesciences - Business Responsibility and Sustainability Reporting (BRSR) |
| Jul 10, 2026, 07:32 PM IST IST | Zydus Lifesciences - Reg. 34 (1) Annual Report. |
| Jul 10, 2026, 07:11 PM IST IST | Zydus Lifesciences - Notice Of Annual General Meeting |
| Jul 08, 2026, 06:14 AM IST IST | Zydus Lifesciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
Source: Dion Global
Zydus Lifesciences Ltd. is a Public Limited Listed company incorporated on 15/05/1995 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1995PLC025878 and registration number is 025878. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 11484.00 Cr. and Equity Capital is Rs. 100.60 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Zydus Lifesciences is ₹1,134.80 as on Jul 14, 2026.
The Zydus Lifesciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Zydus Lifesciences is ₹114,187.43 Cr as on Jul 14, 2026.
Today’s highest and lowest price of Zydus Lifesciences are ₹1,151.60 and ₹1,125.30.
The 52-week high/low is the highest and lowest price at which Zydus Lifesciences stock has traded in the past 52-week or nearly a year. The 52-week high of Zydus Lifesciences is ₹1,181.00 and 52-week low of Zydus Lifesciences is ₹835.85 as on Jul 14, 2026.
The Zydus Lifesciences has shown returns of 0.33% over the past day, 4.33% for the past month, 21.24% over 3 months, 17.17% over 1 year, 24.07% across 3 years, and 12.01% over 5 years.
P/E ratio of and PB ratio of Zydus Lifesciences are 22.66 and 4.21 on Jul 14, 2026. While the company gives a dividend yield of 0.09 per annum.
Source: Dion Global